Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Automated Cell Cultures Market Set To Climb From $7.78 Billion In 2026 To $11.58 Billion By 2030
The automated cell cultures market size has expanded quickly in recent years. It is forecast to grow from $7.02 billion in 2025 to $7.78 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. The historical increase can be attributed to heightened biopharmaceutical research activities, a greater need for standardized cell culture processes, the expansion of drug discovery initiatives, the availability of modular automation solutions, and a rise in academic life science research.
The automated cell cultures market is anticipated to experience rapid expansion over the next few years. It is predicted to grow to $11.58 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This projected growth during the forecast period is primarily driven by escalating investments in cell and gene therapy manufacturing, a rising demand for high-throughput screening, the broadening scope of personalized medicine research, increasing adoption of automation within laboratories, and a heightened focus on scalable biologics production. Major developments expected in this timeframe include the greater deployment of fully automated cell culture platforms, a rising uptake of robotic liquid handling systems, an expanding use of scalable cell culture automation, the proliferation of closed-system cell processing, and an enhanced emphasis on reproducibility and sterility control.
Get A Free Sample Report With In-Depth Market Insights:
Automated Cell Cultures Market Growth Factors Behind Sustained Expansion
The expanding production of biopharmaceuticals is anticipated to drive the advancement of the automated cell cultures market in the future. Biopharmaceuticals are pharmaceutical products created through biotechnology approaches, such as recombinant DNA technology and cell culture methods. The rising need for biopharmaceuticals stems from their capacity to provide precise, potent treatments with reduced adverse effects when contrasted with conventional therapies. Automated cell culture improves both the efficiency and uniformity of biopharmaceutical manufacturing by optimizing processes like cell cultivation, oversight, and collection. For example, in July 2025, Sartorius, an international life science technology firm based in Germany, reported that worldwide sales of biopharmaceutical medicines increased by approximately 9% to hit USD 458 billion in 2024, an increase from the prior year, making up 41% of the total pharmaceutical market, up from 40% in 2023. Consequently, the heightened production of biopharmaceuticals is fueling the expansion of the automated cell cultures market.
Automated Cell Cultures Market Breakdown By Product Type And Application
The automated cell cultures market covered in this report is segmented –
1) By Type: Modular Automation, Whole Label Automation
2) By Equipment Type: Automated Liquid Handling Systems, Microplate Readers, Robotic Systems, Automated Storage And Retrieval Systems, Other Equipment Types
3) By Application: Biopharmaceuticals Production, Diagnostics, Gene Therapy, Drug Screening And Development, Toxicity Testing, Stem Cell Research, Tissue Engineering And Regenerative Medicine, Personalized Medicine, Other Applications
4) By End User: Pharmaceuticals And Biotechnology Companies, Hospital And Diagnostic Laboratories, Research Institutes, Cell Banks
Subsegments:
1) By Modular Automation: Automated Cell Culture Systems, Robotic Workstations, Modular Bioreactors
2) By Whole Label Automation: Fully Automated Cell Culture Systems, Integrated Cell Culture Platforms, Automated Cell Handling Solutions
Automated Cell Cultures Market Industry Trends Fueling Future Revenue Growth
Major companies in the automated cell cultures market are concentrating on technological advancements, such as integrated artificial intelligence (AI)-powered software, to secure a competitive advantage. This integrated AI software within automated cell culture setups optimizes experimental conditions and boosts efficiency by analyzing real-time data to enhance cell growth and productivity. For instance, in October 2023, Molecular Devices LLC, a US-based biotechnology company, introduced the CellXpress.ai Automated Cell Culture System, a breakthrough innovation intended to improve drug discovery processes through advanced automation and artificial intelligence. This system is engineered to streamline complex cell culture workflows, freeing researchers to focus on more critical tasks while simultaneously increasing efficiency and reliability.
Automated Cell Cultures Market Company Landscape And Competitive Strategy
Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec
View The Full Automated Cell Cultures Market Report:
Automated Cell Cultures Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the automated cell cultures market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell cultures market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









